Paris - Delayed Quote EUR

EXOSENS (EXENS.PA)

42.65

+0.20

+(0.47%)

At close: June 13 at 5:35:29 PM GMT+2

Winners of Defense Stock Frenzy in Europe, From Chemical to Goggle Makers

(Bloomberg) -- This year’s surge in Europe’s biggest defense stocks has elicited some obvious winners, leading investors to dig deeper beneath the surface for other names that might stand to benefit from the billions being diverted toward military budgets.Most Read from BloombergNext Stop: Rancho Cucamonga!ICE Moves to DNA-Test Families Targeted for Deportation with New ContractWhere Public Transit Systems Are Bouncing Back Around the WorldUS Housing Agency Vulnerable to Fraud After DOGE Cuts, D

Bloomberg 8 days ago

ALNSE.PA

COHTF

RNMBF
Exosens: Combined General Meeting of 23 May 2025

PRESS RELEASEMÉRIGNAC, FRANCE – 26 MAY 2025 COMBINED GENERAL MEETING OF 23 MAY 2025 The Combined General Meeting (ordinary and extraordinary) of Exosens shareholders (the ‘Company’) was held on Friday 23 May 2025, chaired by Mr Jean-Hubert Vial, Chairman of the Board of Directors. The meeting was attended by Mr Jérôme Cerisier, Chief Executive Officer, Ms Quynh-Boï Demey, Chief Financial Officer, Ms Bella Zisère, Human Resources Director, and the Company's Statutory Auditors. HLD Europe and Bpif

GlobeNewswire 18 days ago

EXENS.PA
+0.47%
European Stocks That May Be Trading Below Their Estimated Value

As European markets experience an upswing, buoyed by improved sentiment following the de-escalation of trade tensions between the U.S. and China, investors are increasingly on the lookout for opportunities that may be trading below their estimated value. In this context, identifying stocks with strong fundamentals and potential for growth can be particularly appealing as they may offer attractive investment prospects amidst a recovering economic landscape.

Simply Wall St. 25 days ago

HAGHY

HNSDF

EXENS.PA
+0.47%
Exosens: Availability of documents and information relating to the Combined General Meeting of 23 May 2025

PRESS RELEASEMÉRIGNAC, FRANCE – 30 APRIL 2025 EXOSENS ANNOUNCES THE AVAILABILITY OF DOCUMENTS AND INFORMATION RELATING TO THE COMBINED GENERAL MEETING OF 23 MAY 2025 Shareholders of Exosens (the ‘Company’) are invited to attend the Combined General Meeting (ordinary and extraordinary) to be held on Friday, 23 May 2025 at 10 a.m. at Apostrophe, 83 avenue Marceau, 75016 Paris, France. The meeting notice, including the agenda and the text of the proposed resolutions, was published in the Bulletin d

GlobeNewswire last month

EXENS.PA
+0.47%
Exosens: Availability of 2024 Universal Registration Document

PRESS RELEASEMÉRIGNAC, FRANCE – 30 APRIL 2025 EXOSENS ANNOUNCES THE AVAILABILITY OF ITS 2024 UNIVERSAL REGISTRATION DOCUMENT Exosens announces today that it has filed its 2024 Universal Registration Document with the French Financial Markets Authority (AMF) on 29 April 2025 under number R.25-001. Exosens‘ 2024 Universal Registration Document contains the Group's 2024 annual financial report, the Group's management report, the Board of Directors’ report on corporate governance and the Group's sus

GlobeNewswire last month

EXENS.PA
+0.47%
Exosens delivers strong revenue growth in Q1 2025 in a dynamic defense market environment; Fully on track to 2025 guidance

EXOSENS DELIVERS STRONG REVENUE GROWTH IN Q1 2025 IN A DYNAMIC DEFENSE MARKET ENVIRONMENT FULLY ON TRACK TO 2025 GUIDANCE HIGHLIGHTS Sustained revenue growth of +21.1% to €104.9m in Q1 2025, reflecting strong like-for-like performance (+18.0%) Continued strong growth in Amplification revenue (+29.1% vs. Q1 2024), driven by a growing demand of image intensifier tubes for Defense night vision applications from NATO and Tier-1 allies forcesDetection & Imaging revenue slightly down (-1.0% vs. Q1 202

GlobeNewswire last month

EXENS.PA
+0.47%
3 European Stocks Estimated To Be Trading At Discounts Of Up To 42.9%

As European markets experience a resurgence, with the pan-European STOXX Europe 600 Index climbing 3.93% over a recent week, investor sentiment has been buoyed by the European Central Bank's rate cuts and delayed tariff impositions. In this environment of renewed optimism, identifying undervalued stocks becomes crucial for investors seeking opportunities to capitalize on potential market corrections and economic shifts.

Simply Wall St. last month

EXENS.PA
+0.47%

SOTDF

SOTDY
EXOSENS JOINS THE SBF 120 INDEX

PRESS RELEASEMÉRIGNAC, FRANCE – 20 MARCH 2025 EXOSENS JOINS THE SBF 120 INDEX Exosens (Ticker: EXENS – ISIN: FR001400Q9V2), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology, announces that it will join the SBF 120 index, which groups the 120 largest companies in terms of liquidity and free-float market capitalization listed on the Euronext Paris stock exchange. The inclusion of Exosens in this index will be effective as of

GlobeNewswire 2 months ago

EXENS.PA
+0.47%
European Stocks With Estimated Discounts Up To 41.3%

Amidst concerns over U.S. trade tariffs and uncertainty in monetary policy, the European markets have experienced a slight downturn, with the pan-European STOXX Europe 600 Index ending 1.23% lower recently. Despite these challenges, investors may find opportunities in undervalued stocks that offer potential for growth by trading below their intrinsic value, making them attractive options in today's cautious market environment.

Simply Wall St. 2 months ago

YARIY

YRAIF

NTCYF
Exosens makes first US investment in night vision production capacity to address growing demand and benefit from new opportunities

EXOSENS MAKES FIRST US INVESTMENT IN NIGHT VISION PRODUCTION CAPACITY TO ADDRESS GROWING DEMAND AND BENEFIT FROM NEW OPPORTUNITIES PRESS RELEASEMÉRIGNAC, FRANCE – MARCH, 3rd 2025 In response to increasing demand, Exosens will invest €20M over the next two years to expand production capacity in both Europe and the U.S.This investment will establish Exosens' first U.S. manufacturing site for producing "Made in America" image intensifier tubesIt strengthens Exosens' position to capture a larger sha

GlobeNewswire 3 months ago

EXENS.PA
+0.47%
Exosens delivers very strong full-year 2024 results, overperforming on its IPO guidance; Sustained growth dynamic anticipated for 2025-2026

EXOSENS DELIVERS VERY STRONG FULL-YEAR 2024 RESULTS, OVERPERFORMING ON ITS IPO GUIDANCE SUSTAINED GROWTH DYNAMIC ANTICIPATED FOR 2025-2026 FY 2024 HIGHLIGHTS Strong revenue growth of +35.0%, above IPO guidance, to €394.1m in 2024, reflecting dynamic like-for-like growth (+24.9%) and successful integration of bolt-on acquisitionsSignificant increase in profitability, with adjusted EBITDA of €118.5m in 2024 (+37.8%), representing a best-in-class margin of 30.1% (vs. 29.5% in 2023), above IPO guida

GlobeNewswire 3 months ago

EXENS.PA
+0.47%
Exosens strengthens its position as a key supplier to Senop for night vision image intensifier tubes highlighting increasing demand for night vision goggles

EXOSENS STRENGTHENS ITS POSITION AS A KEY SUPPLIER TO SENOP FOR NIGHT VISION IMAGE INTENSIFIER TUBES HIGHLIGHTING INCREASING DEMAND FOR NIGHT VISION GOGGLES PRESS RELEASEMÉRIGNAC, FRANCE – FEBRUARY, 24th 2025 Exosens announces that Senop, a Finnish provider of high-tech optronic solutions including night vision goggles, has placed several significant orders for its Photonis white phosphor 4G intensifier tubes, to be delivered over 2025.Third contracts signed with Senop since 2021 confirming Exos

GlobeNewswire 3 months ago

EXENS.PA
+0.47%
February 2025's Top Stocks That May Be Trading Below Estimated Value

As global markets experience a mix of record-high stock indexes and inflation-driven economic uncertainties, investors are keenly observing the shifting landscape for potential opportunities. In this context, identifying stocks that may be trading below their estimated value becomes particularly appealing, as these could offer significant upside potential amidst the current market conditions.

Simply Wall St. 3 months ago

ORINF

ORINY

EXENS.PA
+0.47%
Half-yearly report on Exosens' liquidity contract with Kepler Cheuvreux

PRESS RELEASEMÉRIGNAC, FRANCE – 14 JANUARY 2025 HALF-YEARLY REPORT ON EXOSENS’ LIQUIDITY CONTRACTWITH KEPLER CHEUVREUX In accordance with the provisions of the French Financial Markets Authority’s decisionn°2021-01 of 22 June 2021 renewing the implementation of liquidity contractsfor shares as an accepted market practice Under the liquidity contract entered into between Exosens (Ticker: EXENS; ISIN: FR001400Q9V2) and Kepler Cheuvreux, the following resources appeared on the liquidity account on

GlobeNewswire 4 months ago

EXENS.PA
+0.47%
3 Prominent Stocks Estimated To Be Trading At Discounts Of Up To 49.9% Below Intrinsic Value

As global markets navigate mixed performances and economic uncertainties, investors are increasingly focused on identifying opportunities amid fluctuating indices. Despite recent contractions in manufacturing indices and revised GDP forecasts, the S&P 500 and Nasdaq Composite have managed to post significant gains over the past two years, highlighting potential areas of value. In this context, a good stock is often characterized by its ability to withstand market volatility while being priced...

Simply Wall St. 5 months ago

EXENS.PA
+0.47%

PLXNF

QTGPF
Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth

EXOSENS ANNOUNCES 2024 ESTIMATED RESULTS ABOVE IPO GUIDANCE; 2025 GUIDANCE HIGHLIGHTING LOW TWENTIES ADJUSTED EBITDA GROWTH PRESS RELEASEMÉRIGNAC, FRANCE– 8th JANUARY 2025 2024 estimated figures showing strong revenue growth and sustained profitability, above guidance provided at IPOContinued strong performance expected in 2025, with revenue growth in the high-teens and adjusted EBITDA growth in the low twentiesOverall increased market demand further improves the perspectives which implies a hig

GlobeNewswire 5 months ago

EXENS.PA
+0.47%
German parliament approves the 3rd option of the OCCAR night vision contract under which 25 000 binoculars will be provided equipped with Photonis image intensifier tubes

GERMAN PARLIAMENT APPROVES THE 3rd OPTION OF THE OCCAR NIGHT VISION CONTRACT UNDER WHICH 25 000 BINOCULARS WILL BE PROVIDED EQUIPPED WITH PHOTONIS IMAGE INTENSIFIER TUBES PRESS RELEASEMÉRIGNAC, FRANCE– DECEMBER, 18th, 2024 Germany confirms the exercise of the 3rd option of its OCCAR night vision contract with the Consortium Hensoldt Optronics / THEON providing enhanced night combat capability to the German Armed ForcesIn this framework, Exosens will provide the Consortium with Photonis 16mm imag

GlobeNewswire 5 months ago

EXENS.PA
+0.47%
Exosens joins the MSCI France Small Cap index

PRESS RELEASEMÉRIGNAC, FRANCE – 25 NOVEMBER 2024 EXOSENS JOINS THE MSCI FRANCE SMALL CAP INDEX Exosens (Ticker: EXENS – ISIN: FR001400Q9V2), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology, announces that it will join the MSCI France Small Cap index following the quarterly review of the constituents of MSCI indices. The inclusion of Exosens in this index will be effective as of the market close of 25 November 2024. Exosens

GlobeNewswire 6 months ago

EXENS.PA
+0.47%
Exosens enters into exclusive negotiations to acquire Noxant, specialized in high performance cooled infrared cameras

EXOSENS ENTERS INTO EXCLUSIVE NEGOTIATIONS TO ACQUIRE NOXANT, SPECIALIZED IN HIGH PERFORMANCE COOLED INFRARED CAMERAS PRESS RELEASEMÉRIGNAC – PALAISEAU, FRANCE – NOVEMBER, 18th 2024 Exosens announces it has entered into exclusive negotiations to acquire Noxant, a specialist in high-performance cooled infrared cameras.This acquisition would enhance Exosens' technology platform by adding advanced cooled infrared camera cores for OEM partners, particularly in the Midwave Infrared (MWIR) range.This

GlobeNewswire 6 months ago

EXENS.PA
+0.47%
Exosens: Continued strong growth momentum and significantly improved adjusted gross margin in 9M 2024

PRESS RELEASEMÉRIGNAC, FRANCE – 28 OCTOBER 2024 9M 2024 CONTINUED STRONG GROWTH MOMENTUMAND SIGNIFICANTLY IMPROVED ADJUSTED GROSS MARGIN 2024 GUIDANCE FULLY ON TRACK HIGHLIGHTS Strong revenue growth of +47.4% to €274.4 million in 9M 2024, reflecting a sustained organic growth (+33.1%) and the successful integration of 2023 bolt-on acquisitionsSignificant improvement in adjusted gross margin at €132.8 million in 9M 2024 (48.4% of revenue, +492 bps vs. 9M 2023), driven by higher sales volumes, imp

GlobeNewswire 7 months ago

EXENS.PA
+0.47%

Performance Overview

Return	EXENS.PA	CAC 40 (^FCHI)
YTD	+120.02%	+4.12%
1-Year	+94.58%	-0.30%
3-Year	+77.71%	+27.60%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

EXOSENS (EXENS.PA)

Winners of Defense Stock Frenzy in Europe, From Chemical to Goggle Makers

Exosens: Combined General Meeting of 23 May 2025

European Stocks That May Be Trading Below Their Estimated Value

Exosens: Availability of documents and information relating to the Combined General Meeting of 23 May 2025

Exosens: Availability of 2024 Universal Registration Document

Exosens delivers strong revenue growth in Q1 2025 in a dynamic defense market environment; Fully on track to 2025 guidance

3 European Stocks Estimated To Be Trading At Discounts Of Up To 42.9%

EXOSENS JOINS THE SBF 120 INDEX

European Stocks With Estimated Discounts Up To 41.3%

Exosens makes first US investment in night vision production capacity to address growing demand and benefit from new opportunities

Exosens delivers very strong full-year 2024 results, overperforming on its IPO guidance; Sustained growth dynamic anticipated for 2025-2026

Exosens strengthens its position as a key supplier to Senop for night vision image intensifier tubes highlighting increasing demand for night vision goggles

February 2025's Top Stocks That May Be Trading Below Estimated Value

Half-yearly report on Exosens' liquidity contract with Kepler Cheuvreux

3 Prominent Stocks Estimated To Be Trading At Discounts Of Up To 49.9% Below Intrinsic Value

Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth

German parliament approves the 3rd option of the OCCAR night vision contract under which 25 000 binoculars will be provided equipped with Photonis image intensifier tubes

Exosens joins the MSCI France Small Cap index

Exosens enters into exclusive negotiations to acquire Noxant, specialized in high performance cooled infrared cameras

Exosens: Continued strong growth momentum and significantly improved adjusted gross margin in 9M 2024

Performance Overview